Abdul Ezaz Mutlib
Chief Executive Officer bei FRONTAGE HOLDINGS CORPORATION
Vermögen: 75 638 $ am 31.03.2024
Profil
Abdul Ezaz Mutlib is currently the Chief Executive Officer at Frontage Laboratories, Inc. since 2010.
He is also the Chief Executive Officer at Frontage Holdings Corp.
since 2017.
Additionally, Dr. Mutlib has been a Member of the American Society For Mass Spectrometry since 1990.
In the past, he worked as the Director-Drug Metabolism at Pfizer Inc. from 2006 to 2010.
He also held positions as a Principal at Wyeth LLC, DuPont Merck Pharmaceutical Co., and Hoechst-Roussel Pharmaceuticals, Inc. Dr. Mutlib completed his undergraduate degree at The University of Sydney in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FRONTAGE HOLDINGS CORP.
0,02% | 26.01.2024 | 411 098 ( 0,02% ) | 75 638 $ | 31.03.2024 |
Aktive Positionen von Abdul Ezaz Mutlib
| Unternehmen | Position | Beginn |
|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Chief Executive Officer | 03.01.2023 |
Frontage Laboratories, Inc.
 Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Chief Executive Officer | 01.01.2010 |
| American Society For Mass Spectrometry | Corporate Officer/Principal | 01.01.1990 |
Ehemalige bekannte Positionen von Abdul Ezaz Mutlib
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.02.2010 |
| Hoechst-Roussel Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Ausbildung von Abdul Ezaz Mutlib
| The University of Sydney | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| FRONTAGE HOLDINGS CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Frontage Laboratories, Inc.
Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Commercial Services |
| Hoechst-Roussel Pharmaceuticals, Inc. | |
| American Society For Mass Spectrometry |
